Since their release to the general public last year, the US government has been purchasing and providing COVID-19 vaccines free of charge to patients. With this program set to end soon as public demand for the vaccine draws down, Pfizer is looking to hike its price up by 400% as it enters the commercial market.
According to Kevin Dunleavy, “In the last supply contract the U.S. signed with Pfizer and BioNTech in June of this year, the companies charged $30.48 per dose, which was an increase from a $24 price in July of 2021 and $19.50 per dose in July of 2020.”
To read more, click here.
(Source: Fierce Pharma, October 21st, 2022)